Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-01

Clinical Trial Update: PRP Treatment of Osteoarthritic Knee With a New Autologous Blood Product (CytoRich) [NA]

View source ↗

Summary

A clinical trial update describes using an autologous blood product called CytoRich to treat osteoarthritis of the knee in a PRP-based approach, sponsored by An…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CytoRich

Snippet

Sponsor: Antnor | Conditions: Osteoarthritis of the Knee | NA | Status: UNKNOWN